Progression-Free Survival: An Important Prognostic Marker for Long-Term Survival of Small Cell Lung Cancer

BACKGROUND: Small cell lung cancer (SCLC) is an extremely aggressive tumor with a poor clinical course. Although many efforts have been made to improve patients' survival rates, patients who survive longer than 2 years after chemotherapy are still very rare. We examined the baseline characteris...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Myoung-Rin, Park, Yeon-Hee, Choi, Jae-Woo, Park, Dong-Il, Chung, Chae-Uk, Moon, Jae-Young, Park, Hee-Sun, Jung, Sung-Soo, Kim, Ju-Ock, Kim, Sun-Young, Lee, Jeong-Eun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Tuberculosis and Respiratory Diseases 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4050069/
https://www.ncbi.nlm.nih.gov/pubmed/24920948
http://dx.doi.org/10.4046/trd.2014.76.5.218

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4050069/
https://www.ncbi.nlm.nih.gov/pubmed/24920948
http://dx.doi.org/10.4046/trd.2014.76.5.218

Ejemplares similares